* Mesa Laboratories Inc MLAB.OQ reported a quarterly
adjusted
loss of 34 cents per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was
for earnings of 48 cents per share.
* Revenue rose 55.1% to $58.88 million from a year ago;
analysts
expected $55.40 million.
* Mesa Laboratories Inc's reported EPS for the quarter was a
loss
of 34 cents.
* The mean earnings estimate of analysts had risen by
about 5.5%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Mesa Laboratories Inc shares had fallen by 14.8% this
quarter and lost 33.8% so far this year.
* The company reported a quarterly loss of $1.78 million.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $330.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated May 31 at 12:55 p.m. All
figures in US dollars unless otherwise stated